Overview
This study aims to investigate the effects of a single dose of the glucagon-like 1 receptor agonist semaglutdie/Rybelsus on the hypothalamo-pituitary-adrenal axis, thus cortisol levels and other stresshormones in healthy males.
Eligibility
Inclusion Criteria:
- Healthy male volunteers aged 18-60 years
- BMI 18.5-30 kg/m2
- No regular medication
Exclusion Criteria:
- participation in a trial with investigational drugs within 30 days
- vigorous physical exercise within 24 hours before the study participation
- alcohol intake within 24 hours before the study participation
- a history of intake of glucocorticoids or GLP-1 RA within the last 8 weeks.
- Known allergy towards GLP-1 RA